3 month supply tirzepatide Compounded Weight Management Program — 3-Month Plan Affordable Tirzepatide for Weight Loss

have had their lives changed by GLP-1 medications

We prescribe FDA-approved semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) to help patients lose 15-22% of their body weight safely and effectively

Myth: GLP-1 Agonists Cause Heart Issues There is no evidence showing that GLP-1s cause heart disease

M., Nerobkova, L

In conclusion, microenvironmental heterogeneity across oncologic, metabolic, neurologic, cardiovascular, and immune-related disorders presents a pervasive and dynamic challenge for GLP-1R-targeted nanomedicines

They must meet with a health care provider and have quarterly blood work to continue the program for additional weight loss or help with maintenance